Introduction
Human Immunodeficiency Virus (HIV) an infection/acquired immunodeficiency syndrome (AIDS) was the fifth main reason behind dying and poses a big illness burden amongst Thai individuals.1 The incidence per 1000 inhabitants was 0.08 for all ages, with an estimated 5400 new HIV infections per 12 months.2,3 Since 2014, HIV/AIDS pointers have been developed in collaboration with the Division of Illness Management, Ministry of Public Well being and the Thai AIDS Society, with a big change that folks residing with HIV can now entry antiretroviral remedy (ART) without spending a dime and instantly upon prognosis.4 This was in step with the advice of the United State (US) Division of Well being and Human Companies (DHHS) panel denoting that ART must be offered to all HIV-positive people.5 Till now, individuals residing with HIV have been handled without spending a dime by way of the assist of all Thai medical health insurance schemes. Nevertheless, drug-related adversarial drug reactions (ADRs) steadily result in non-compliance, virological failure, substantial remedy prices, and poor high quality of life, given that folks residing with HIV are extra vulnerable to ADRs than the overall inhabitants. It has been nicely acknowledged that HIV remedy consisting of ART and opportunistic infections may cause severe ADRs together with abacavir-induced hypersensitivity response (HSR), co-trimoxazole-induced Stevens-Johnson syndrome and poisonous epidermal necrolysis (SJS/TEN), drug-induced rash with eosinophilia and systemic signs (DRESS), and isoniazid-induced hepatotoxicity.6
These days, genetic components are extensively recognized to affect the efficacy and toxicity of pharmacological remedy.7 Supporting this, quite a few research demonstrated important associations between genetic polymorphisms and drug induced-serious ADRs in not solely ART regimens like abacavir, but additionally opportunistic an infection remedy together with co-trimoxazole, dapsone, and isoniazid.7,8 Along with these earlier findings, a meta-analysis uncovered that sufferers who carried HLA-B*57:01 have been extra seemingly than non-carriers to develop abacavir-induced HSR.9 Based mostly on this premise, america Meals and Drug Administration (USFDA) really helpful that HLA-B*57:01 genetic screening must be commonplace apply for all sufferers receiving abacavir remedy.10 Other than the numerous affect of HLA-B*57:01 related to abacavir-induced HSR, additional meta-analysis and phenotype stratification research revealed a considerable affiliation between HLA-B*13:01 and co-trimoxazole–induced DRESS.11 In Thai individuals, HLAB*13:01 allele was noticed to be considerably related to co-trimoxazole-induced SJS/TEN when in comparison with co-trimoxazole-tolerant controls.12 In Thai non-leprosy sufferers, HLA-B*13:01 was additionally considerably related to dapsone-induced extreme cutaneous adversarial reactions (SCARs). Except for results of HLA genetic polymorphisms on drug induced-serious ADRs, a number of meta-analyses demonstrated that tuberculosis (TB) sufferers with sluggish/intermediate N-acetyltransferase 2 (NAT2) acetylators had a better threat of isoniazid-induced liver damage than these with fast acetylators.13,14 The aforementioned findings lend assist to the notion that figuring out genetic polymorphisms of pharmacogenes could pave the way in which to personalised medication within the context of ADRs.
In assist of the above assumption, beforehand printed findings indicated that performing pharmacogenetic (PGx) testing earlier than prescribing medicine would possibly assist scale back the danger of growing severe ADRs.9,11–14 In Thailand, solely HLA-B*15:02 testing is required earlier than prescription carbamazepine for epilepsy sufferers, and HLA B*57:01 testing is required earlier than prescription allopurinol for gout sufferers underneath the Common Well being Protection (UHC) scheme, which covers round 80% of Thai inhabitants. Regardless of this, there are over 70 PGx assessments accessible at medical faculty laboratories and 14 regional lab facilities operated by the Division of Medical Sciences, Ministry of Public Well being.15 Thus far, technological developments like a sequencing technique have made it attainable to check quite a few genes in a brief time period, which can have a better predictive worth than single-gene testing. Subsequently, multiple-PGx testing might be essential to discover quite a lot of potential remedy pathways.16 Nevertheless, the price of multiple-PGx testing remains to be costly, and no cost-effectiveness info has been offered to help policymakers in making rationale useful resource allocation resolution. Accordingly, the aim of this research was to judge the cost-utility of single-PGx testing of HLA-B*57:01 earlier than prescribing abacavir to forestall HSR, HLA-B*13:01 earlier than prescribing co-trimoxazole to forestall DRESS, HLA-B*13:01 earlier than prescribing dapsone to forestall SCAR, and NAT2 earlier than prescribing isoniazid to forestall hepatotoxicity in individuals residing with HIV in addition to multiple-PGx testing, which is a mixture of 4 aforementioned single-PGx assessments in comparison with no PGx testing as a present apply.
Supplies and Strategies
Examine Design
A hybrid resolution tree and Markov mannequin was developed to judge a cost-utility of a single- and multiple-PGx testing technique earlier than beginning drug remedy in individuals residing with HIV in contrast with these prescribed drug remedy with out PGx testing. The incremental cost-effectiveness ratio (ICER) was calculated when it comes to price per quality-adjusted life-year (QALY). The evaluation was produced from a societal perspective.
Goal Inhabitants
The mannequin simulated cohorts of newly recognized HIV sufferers who obtained ART and remedy for opportunistic infections akin to Pneumocystis jiroveci Pneumonia (PCP) and TB.
Interventions and Comparator
Studied interventions included 4 single-PGx assessments and multiple-PGx testing that merged these single-PGx assessments, which have been all in comparison with no PGx testing as a present apply. The next particulars have been offered.
Single-PGx Testing
Single PGx testing included 1) HLA-B*57:01 earlier than beginning abacavir to forestall HSR,6 2) HLA-B*13:01 earlier than prescribing co-trimoxazole to forestall DRESS, 3) HLA-B*13:01 earlier than prescribing dapsone to forestall SCAR, and 4) NAT2 earlier than prescribing isoniazid to forestall hepatotoxicity.17 Previous to initiating any medicine routine, newly recognized HIV sufferers have been all examined sequentially. Sufferers who get a optimistic take a look at consequence can be prescribed the choice routine, whereas these with a unfavourable take a look at consequence would proceed the preliminary routine.
A number of-PGx Testing
A number of-PGx testing included 4 single-PGx assessments in a single panel. Sufferers who take a look at optimistic for every take a look at can be prescribed the choice routine, whereas sufferers who take a look at unfavourable would stay on the preliminary routine. All newly recognized HIV sufferers have been examined simply as soon as earlier than beginning drug remedy.
No PGx Testing
Sufferers newly recognized with HIV an infection have been handled with the first-line ART routine and opportunistic an infection remedy with out present process PGx testing. Based mostly on the Thailand’s Nationwide Tips on HIV/AIDS Analysis, Remedy, and Prevention 2020/2021,6 the first-line NRTI spine routine consists of a mixture of tenofovir/emtricitabine (TDF 300 milligram (mg)/FTC 200 mg or TAF 25 mg/FTC 200 mg) plus dolutegravir (DTG) 50 mg, tenofovir-containing regimens. If sufferers developed severe ADRs as a result of first-line remedy, abacavir/lamivudine (ABC 600 mg/3TC 300 mg) with DTG 50 mg, abacavir-containing regimens can be really helpful because the second-line ART routine. If a affected person taking abacavir developed a suspected HSR, zidovudine/lamivudine (AZT 600 mg/3TC 300 mg) with DTG 50 mg, zidovudine-containing routine really helpful because the third-line ART routine. Consequently, the ART routine was offered life-long remedy.
Based mostly on Thailand’s Nationwide Tips on HIV/AIDS Analysis and worldwide pointers, co-trimoxazole or trimethoprim/sulfamethoxazole (TMP/SMX), 80 mg TMP plus 400 mg SMX (1–2 tablets) every day or 160 mg TMP plus 800 mg SMX 3 times per week was really helpful because the drug of alternative for major prophylaxis of PCP in individuals residing with HIV. Whereas 15 to twenty mg/kg (based mostly on the TMP element) given in 3 or 4 equally divided doses each 6 to eight hours for as much as 14 days was really helpful for the remedy of PCP.6,18,19 In sufferers who had severe ADRs to co-trimoxazole or different sulfa-drugs, both dapsone 100 mg every day or intravenous pentamidine 300 mg month-to-month might be used in its place for PCP prophylaxis.20,21 Furthermore, clindamycin 600 mg plus primaquine 30 mg for 21 days might be used because the remedy of PCP.22
Concerning TB an infection, the Thailand Nationwide Tips on TB/HIV and the World Well being Group (WHO) really helpful the first-line remedy routine for TB comprising a mixture of isoniazid 5–8 mg/kg (or 300 mg), rifampicin 10 mg/kg (or 450–600 mg), pyrazinamide 25 mg/kg (or 1000–2000 mg), and ethambutol 25 mg/kg (or 800–1200 mg) as an preliminary remedy routine for the primary two months adopted by isoniazid and rifampicin for 4 months.23,24 In sufferers who developed hepatotoxicity, half the usual isoniazid dosage for 9 months was really helpful to forestall hepatotoxicity from isoniazid.25–27
Mannequin Construction
A mix of a hybrid of resolution tree and Markov fashions was constructed based mostly on the medical apply in accordance with the Thailand’s Nationwide Tips on HIV/AIDS Analysis, Remedy, and Prevention 2020/2021.6 The mannequin was used to find out lifetime prices and well being outcomes between individuals residing with HIV receiving both single or a number of PGx testing earlier than beginning drug remedy in contrast with those that didn’t get PGx testing. From this, the mannequin began with the identical grownup cohort, people newly recognized HIV and aged greater than 30 years outdated. The lifetime time horizon was employed with a one-year cycle size. Prices and outcomes have been discounted at a fee of three% every year based mostly on Thailand’s and the World Well being Group’s pointers for well being know-how evaluation.28,29
Determine 1A depicts the choice tree mannequin displaying three remedy choices for newly recognized HIV-infected sufferers, particularly no PGx testing, single-PGx testing, and multiple-PGx testing, which mixed 4 single-PGx assessments in a single panel. If the sufferers had a optimistic take a look at results of every testing, they might obtain the choice drug routine. The primary-line ART remedy begins with tenofovir-containing regimens; in the event that they develop severe ADRs akin to nephrotoxicity or if tenofovir is contraindicated, they’re switched to ABC-containing regimens. Afterwards, when the situation progressed, remedy for opportunistic an infection was offered.
 |
Determine 1 (A) Choice tree mannequin. (B) Choice tree mannequin (proceed). (C) Markov mannequin. Abbreviations: ABC, abacavir; ADR, adversarial drug response; ART, Aantiretroviral remedy; Asym, asymptomatic; Cotri, Co-trimoxazole; INH, isoniazid; OI, opportunistic an infection; NAT2, N-acetyltransferase 2; PCP, pneumocystis pneumonia; Prophy, prophylaxis; Sym, symptomatic; TB, tuberculosis; TDF, tenofovir; Tm, remedy. |
5 attainable occasions have been recognized in sufferers with CD4 counts <200 cells per mm3: 1) asymptomatic HIV an infection: sufferers would initially obtain ART, co-trimoxazole prophylaxis and INH for latent TB; 2) symptomatic PCP an infection: sufferers would begin with ART, co-trimoxazole remedy and INH for latent TB; 3) symptomatic TB an infection: sufferers would begin with ART and INH remedy for TB an infection and co-trimoxazole prophylaxis; 4) symptomatic PCP and TB infections: sufferers would begin with ART and co-trimoxazole remedy and INH remedy; and 5) different opportunistic infections: sufferers would begin with ART and different opportunistic an infection remedy akin to cryptococcal meningitis and toxoplasma encephalitis. For affected person with CD4 counts ≥200 cells per mm3, two attainable occasions have been recognized: 1) asymptomatic HIV an infection: sufferers would begin with ART and a couple of) symptomatic TB an infection: sufferers would begin with ART and INH remedy.
All methods had potential outcomes, together with 1) the event of significant ADRs, 2) different ADRs associated to drug remedy, and three) the absence of ADRs. The advantage of PGx testing methods was to forestall severe ADRs related to preliminary drug routine by modifying the remedy routine if the take a look at outcomes have been optimistic, whereas sufferers with a unfavourable take a look at consequence would proceed to obtain the unique drug routine (Determine 1B).
In every technique, a Markov mannequin was used to signify the lifetime price and well being outcomes related to the adoption of ART routine and opportunistic an infection remedy (Determine 1C). Sufferers who didn’t purchase any ADRs might stay on this well being state or die through the subsequent cycle, as proven in Determine 1C (M1). Sufferers who developed different ADRs might progress to well being state of treatment or die within the subsequent cycle (Determine 1C, M2), whereas sufferers who developed severe ADR might progress to well being state of treatment or die on account of these severe ADRs, as proven in Determine 1C (M3). Severe ADRs could also be deadly if medicine are usually not promptly discontinued. Subsequently, sufferers who developed severe ADRs (ie, HSR related to abacavir, DRESS related to co-trimoxazole, and SCAR related to dapsone) can be eliminated off them. Apart from hepatotoxicity related to isoniazid, the dosage was halved for sluggish acetylators.
Mannequin Assumptions
The next assumptions have been used on this research: 1) no distinction within the effectiveness between the first-line and various regimens (ie, tenofovir, abacavir and zidovudine-containing regimens) was assumed, 2) sufferers have been assumed to stick to remedy utterly, and three) since no multiple-PGx testing for individuals residing with HIV was accessible available on the market on the time of this research, its sensitivity and specificity have been assumed to be equal to 0.99 referred from the PGxOne™,30 the panel testing masking greater than 60 PGx assessments in a single panel from main therapeutic areas together with gene-drug pairs on this research (ie, HLA-B*57:01, HLA-B*13:01, and NAT2) and at present accessible available in the market, and 4) The price of multiple-PGx testing was assumed to be equal to the whole price of 4 single PGx assessments (ie, HLA-B*57:01 earlier than prescribing abacavir, HLA-B*13:01 earlier than prescribing co-trimoxazole and dapsone, and NAT2 earlier than prescribing isoniazid) within the base-case situation.
Mannequin Parameters
The enter parameters used within the mannequin have been categorised into 4 main teams: epidemiological information and transition possibilities, effectiveness of testing, prices information, and utility parameters. The parameter values are offered in Desk 1.
 |
 |
 |
 |
Desk 1 Mannequin Parameters within the Base-Case Evaluation |
Epidemiological Knowledge and Transition Possibilities
The incidence of asymptomatic HIV, symptomatic PCP, or TB sufferers was retrieved from printed research,31,32 which have been carried out in Thai individuals residing with HIV earlier than beginning ART. The bottom-case situation adopted the frequencies of HLA-B*13:01 and NAT2 alleles in Thai HIV-positive individuals,12,33,34 whereas the frequency of HLA-B*57:01 allele was obtained from white HIV-positive individuals in Europe and Australia by way of the PREDICT-1 research.35 Furthermore, The annual mortality charges amongst HIV asymptomatic, HIV symptomatic, and AIDS sufferers have been estimated utilizing information from two cohort research of 880 individuals residing with HIV in Thailand.36–38 The all-cause mortality fee was derived from the Thai Burden of Illness and Damage Examine and was adjusted for age,1 whereas mortality fee brought on by HSR, DRESS, and SCAR was set at 10%, and hepatotoxicity was 1%.39–41
Effectiveness of Testing
Within the base-case situation, the chance of drug-induced severe ADRs in sufferers testing optimistic for any allele or optimistic predictive worth (PPV) was retrieved from printed genetic affiliation research primarily specializing in Thai inhabitants,12,33 with exception of HLA-B*57:01 research, through which the chance was obtained from PREDICT-1 research.35 Furthermore, the sensitivity and specificity of single-PGx testing have been specified by the producer, whereas these of a number of PGx testing have been assumed to be equal to 0.99, referred from PGxOne™, which coated greater than 60 PGx assessments in a single panel from main therapeutic areas, together with gene-drug pairs on this research, ie, HLA-B*57:01, HLA-B*13:01 and NAT2.30
Value
All prices have been transformed and reported in 2022 Thai baht (THB) values utilizing the Thai shopper value index.42 Value evaluation was carried out based mostly on a societal perspective, making an allowance for each direct medical and non-medical prices. Direct medical prices included prices of ART regimens and opportunistic an infection remedy, HIV remedy, ADRs administration, single- and multiple-PGx testing. Prices of ART regimens and opportunistic an infection remedy have been calculated utilizing the unit costs based mostly on public hospital’s prevailing acquisition prices in 2022, introduced by the Drug and Medical Provide Info Middle (DMSIC), Ministry of Public Well being.43 As well as, prices related to HIV remedy together with laboratory assessments, hospitalization, and outpatient division (OPD) follow-up have been obtained from a printed research.36 These prices have been calculated by multiplying the variety of providers utilized by their unit price. Prices of managing ADRs together with abacavir-induced hypersensitivity, co-trimoxazole-induced DRESS, dapsone-induced SCAR, and isoniazid-induced hepatotoxicity have been retrieved from Buddhachinaraj Phitsanulok hospital databases containing a complete of 465 individuals residing with HIV aged 18 years or older who have been hospitalized with severe ADRs in 2015 to 2019. Value of single-PGx testing was estimated utilizing the reimbursement value of the Nationwide Well being Safety Workplace (NHSO).44 On account of lack of information on price of multiple-PGx testing, we assumed that it was equal to the whole price of three single-PGx assessments (ie, HLA-B*57:01, HLA-B*13:01, and NAT2). Nonetheless, the price’s larger and higher bounds have been utilized to the uncertainty evaluation.
Furthermore, direct non-medical prices associated to ADRs remedy together with transportation to hospitals, meals for sufferers and caregivers, paid caregiver, and casual care (unpaid caregiver) have been collected by way of interviews with 93 sufferers who had skilled severe ADRs in OPD from the aforementioned hospital.
Utility
Well being outcomes have been represented as quality-adjusted life-years (QALYs), that are calculated by the multiplying life years (LYs) by their utility rating. The utility values (0 = dying and 1 = full well being) for every well being state (ie, hypersensitivity and treatment) and a lower in utility (or disutility) in sufferers who developed ADRs like hypersensitivity syndrome have been obtained from printed literatures, along with remedy attributes akin to dosing frequency (greater than as soon as per day) and the variety of prescribed drugs per day that contributed to the disutility.36,39,45,46
Outcome Presentation
The outcomes have been in comparison with the quantity wanted to display (NNS) for PGx testing with a purpose to stop one incidence of significant ADRs. Whole price, Lys, and QALYs of three options have been estimated. The incremental cost-effectiveness ratio (ICER) was calculated by incremental price divided by incremental QALY of single-PGx or multiple-PGx testing and in comparison with that of no testing. As really helpful by the rules for well being know-how evaluation in Thailand,29 the Thai societal willingness-to-pay threshold (WTP) of 160,000 THB per QALY gained was utilized.
Uncertainty Evaluation
Parameter Uncertainty
To handle the uncertainty of all enter parameters and assess their results on the mannequin, one-way deterministic sensitivity evaluation (DSA) and multivariate probabilistic sensitivity evaluation (PSA) have been carried out. DSA was carried out by various every enter parameter inside its 95% CI, and the Twister diagram was used to show the vary of ICER values. Furthermore, PSA utilizing a 1000-time Monte Carlo simulation was carried out to judge uncertainty of all parameters concurrently with acceptable statistical distributions for every parameter, particularly the beta-distribution for dangers and utility and the gamma distribution for prices parameters. The price-effectiveness acceptability curve (CEAC) was used for example the possibilities of every various being cost-effective relative to a specified WTP threshold.
Situation Evaluation
The situation analyses have been carried out by various the prevalence and PPV of HLA-B*57:01, HLA-B*13:01, and NAT2, as these parameters would possibly have an effect on the ICER values. The prevalence was estimated utilizing the intense values on the larger and decrease bounds of prevalence in different setting. The prevalence of HLA-B*57:01 was estimated to be 9.5% in Jap Europe ethnicity47 and 1.1% in Han Chinese language.48 For HLA-B*13:01, 28% of Papuans and Australian aborigines and 0% of European and African populations49 have been thought of. For NAT2, 66% of the UK Caucasian and 10% of Korean inhabitants50 have been utilized. Moreover, higher and decrease bounds for the PPV have been set at 50% of the bottom case values.
Threshold Evaluation
Threshold evaluation was undertaken to find out the ICER, through which the price of multiple-PGx testing and the vary of its sensitivity and specificity have been different. This evaluation sought to find out the edge at which level the choice can be altered (ie, the place the ICER confirmed that the testing was not cost-effective).
Outcomes
Base-Case Evaluation
In contrast with no PGx testing, PGx testing previous to initiating drug remedy might keep away from the variety of severe ADR circumstances (ie, abacavir-induced HSR, co-trimoxazole-induced DRESS, dapsone-induced SCAR and isoniazid-induced hepatotoxicity) by roughly 68 circumstances per 12 months (Determine 2). Moreover, the quantity wanted to display (NNS) confirmed that 40 sufferers wanted to be examined for these PGx assessments to forestall one case of significant ADR.
 |
Determine 2 The incidence of significant ADRs related to Abacavir, co-trimoxazole and isoniazid when offering the multiple-pharmacogenetic testing. Abbreviations: ADRs, adversarial Ddrug reactions; FDA, Meals and Drug Administration. |
The full lifetime price, LYs, QALYs, and ICER based mostly on the societal perspective are detailed in Desk 2. In contrast with no PGx testing, single and multiple-PGx testing have been each discovered to extend LYs and QALYs. Whole LYs and QALYs have been 24.87 LYs and 20.83 QALYs within the absence of PGx testing, 24.92 LYs and 20.88 QALYs for single-PGx testing, and 24.96 LYs and 20.91 QALYs for multiple-PGx testing. The lifetime prices of single-PGx and multiple-PGx testing have been elevated by roughly 8101 and 13,171 THB per affected person, respectively, whereas QALYs have been elevated by 0.06 and 0.09, respectively, as in contrast with no PGx testing. These outcomes indicated that single- and multiple-PGx assessments have been extra barely larger prices and extra advantageous than initiating drug remedy with out PGx testing, owing to the price financial savings related to ADR remedy. Consequently, roughly 35% and 40% of the price of ADR remedy might be prevented by the implementation of single- and multiple-PGx testing, respectively.
 |
Desk 2 Outcomes of Whole Lifetime Prices and Well being Outcomes from the Base-Case Evaluation Utilizing a Societal Perspective |
The incremental cost-effectiveness ratio was estimated at 146,319 THB/QALY gained for single-PGx testing technique and 152,014 THB/QALY gained for multiple-PGx testing in contrast with no PGx testing.
Uncertainty Evaluation Outcomes
The parameters influencing sensitivity of the ICER for multiple-PGx testing have been the price of ABC-containing regimens, the price of TDF-containing regimens and chance of dying from DRESS, respectively (Determine S1 in Supplementary Supplies). Moreover, when the WTP was 160,000 THB per QALY gained, chance of multiple-PGx testing being cost-effective was 45%, in comparison with no PGx testing (42%) and single-PGx testing (13%). Furthermore, you will need to be aware that the cost-effectiveness of the multiple-PGx testing elevated in correlation with the WTP threshold (Determine 3). The price-effectiveness airplane confirmed that single- and multiple-PGx testing have been dearer and more practical than no testing (Determine S2 in Supplementary Supplies). Moreover, outcomes advised that there are a number of uncertainties across the imply of the ICER.
 |
Determine 3 Value-effectiveness acceptability curves evaluating the possibilities of being cost-effective at totally different willingness-to-pay of the non-PGx testing, single-PGx testing, and multiple-PGx testing. Abbreviations: PGx, pharmacogenetic; QALY, quality-adjusted life-year; THB, Thai baht. |
The situation analyses have been carried out by various the worth of prevalence and PPV of HLA-B*57:01, HLA-B*13:01, and NAT2. Outcomes from situation analyses indicated that will increase in prevalence and PPV of these assessments would possibly lead to barely elevated the price and QALYs of single-PGx testing. Nevertheless, most situations proceed to be cost-effective (Desk S1 in Supplementary Supplies).
Desk 3 presents outcomes of threshold evaluation upon the ICER of every situation when the price of multiple-PGx testing and a spread of sensitivity and specificity have been different. In comparison with no PGx testing, multiple-PGx testing was proven to be cost-effective underneath the vary of specificity at 0.98–1.00 and sensitivity at 0.95–1.00 in addition to the vary price of multiple-PGx testing. For instance, if sensitivity and specificity of multiple-PGx testing have been each 0.99, multiple-PGx testing can be cost-effective when the price was lower than 3000 THB, however not when the price exceeded 3000 THB.
 |
Desk 3 Threshold Evaluation Displaying the Incremental Value-Effectiveness Ratios (ICER) of Every Situation, Categorized by Value, Sensitivity and Specificity of A number of-Pharmacogenetic Testing |
Dialogue
To the perfect of our information, this research was the primary to analyze the cost-utility of single- and multiple-PGx testing earlier than beginning drug remedy in individuals residing with HIV in comparison with no PGx testing as a present apply. Our outcomes advised that each single- and multiple-PGx testing might assist stop severe ADRs and scale back the prices of ADR remedy. Furthermore, the NNS demonstrated that 40 sufferers wanted to be examined for these PGx to forestall one case of significant ADR. From a societal perspective, each single- and multiple-PGx testing have been cost-effective methods, indicating that they have been dearer and more practical than initiating drug remedy with out PGx testing. Furthermore, the chance of multiple-PGx testing being cost-effective was 45% in comparison with no PGx testing (42%) and single-PGx testing (13%) on the Thai willingness to pay threshold of 160,000 THB per QALY.
At the moment, though 4 single PGx testing can be found in Thailand and must be carried out solely as soon as in a lifetime of individuals residing with HIV, there’s nonetheless low protection fee of those PGx testing provided that these assessments haven’t been included within the UCS well being profit on account of restricted cost-effectiveness info. Therefore, the findings from this research might be used to information policymakers on whether or not to incorporate both single- or multiple-PGx testing within the UCS well being profit package deal. These PGx assessments could assist in not solely figuring out the a number of causative genes, but additionally in growing optimum remedy methods based mostly on the Nationwide Thai HIV remedy pointers. Along with this, capability of PGx providers when it comes to a referral pathway and genetic counselling providers must be thought of, whereas implementing PGx. Alongside this, threshold evaluation revealed that multiple-PGx testing was nonetheless cost-effective in comparison with no PGx testing underneath the vary of sensitivity at 0.95–1.00 and specificity at 0.98–1.00 in addition to the vary price of multiple-PGx testing. This info can be utilized to help within the improvement of multiple-PGx testing earlier than beginning drug remedy in individuals residing with HIV. In parallel with threshold evaluation, provided that the situation evaluation utilizing a variety of essential parameter values have been carried out, the discovering can be generalizable to different settings. Moreover, the developed technique for figuring out the cost-effectiveness of multiple-PGx testing for stopping drug-induced severe ADRs in individuals residing with HIV could also be utilized to evaluate worth for cash take a look at in different medical settings.
This research additionally offered supporting information on host genetic components in ADRs, which can be useful in lowering the detrimental impact of drug-induced severe ADRs. Our findings could also be thought of an extension of conventional strategy for treating a illness, which permits clinicians to decide on a drugs remedy or intervention based mostly on a affected person’s genetic profile, a course of generally known as personalised medication. Moreover, PGx testing has a big impression on the rational use of medicine by lowering the event of negative effects and stopping inappropriate remedy adjustment. This will have each therapeutic and financial advantages.
Nevertheless, it must be famous that some inherent limitations of this research have to be taken under consideration. First, our evaluation didn’t contemplate the opportunity of totally different remedy regimens, drug resistance, and poor adherence, that are all conceivable in actual apply. Apart from this, every severe ADRs and different ADRs associated to drug remedy occurred solely as soon as through the first 12 months, and we didn’t contemplate lifelong ADRs or problems. This will result in an underestimated worth of the one-off testing. Second, as a result of shortage of native information, two enter parameters have been gathered from different nations. One other caveat is the truth that the prevalence of HLA-B*57:01 was obtained from the PREDICT-1 trial,35 a randomized, multicenter, double-blind trial of HLAB*57:01 genotyping abacavir-related HSRs in white Caucasians or Europeans. Nevertheless, HLA-B*57:01 testing was included on this research, as a result of abacavir-containing routine can be an important element of an ART spine routine as a second-line remedy choice for sufferers who had extreme ADRs as a consequence of tenofovir or for whom tenofovir was contraindicated. As well as, the Thailand Nationwide Tips on HIV/AIDS talked about that HLA-B*57:01 must be examined earlier than beginning abacavir to forestall HSR.6 With a purpose to account for this constraint, we carried out an uncertainty evaluation to evaluate its results on the ICER. For the opposite parameter, dosage changes of isoniazid have been made in Europe and Japan based mostly on NAT2 genotype-guided routine to keep away from hepatotoxicity.25–27 Taking these limitations under consideration, nevertheless, we carried out one-way and PSA to look at the impact of every parameter on the ICER outcomes. Lastly, we have been unable to find out the affordability and skill to implement PGxs testing. To handle this problem, price range impression and feasibility analyses must be executed in a future research.
Conclusion
Our findings indicated that each multiple- and single-PGx testing earlier than prescribing HIV remedy might stop severe ADRs and scale back the prices of ADR remedy. Collectively, provided that genetic polymorphisms of a number of pharmacogenes have been proven to be concerned in drug-induced severe ADRs, single- and multiple-PGx testing can be cost-effective choices for stopping drug-induced severe ADRs in individuals residing with HIV.
Ethics Approval
This research used anonymized and aggregated information associated to the price of managing ADRs carried out by our analysis staff. All members have been required to supply written knowledgeable consent earlier than enrolling and the graduation of the research. Moral approval was granted by the Institutional Evaluate Boards (IRB), Mahidol College (COA.No.MU-DT/PY-IRB 2020/016.1603) by way of the expedited assessment process. All procedures carried out within the research complied with worldwide pointers for human analysis safety, such because the Declaration of Helsinki and the Belmont Report.
Acknowledgments
This work is part of a research in Physician of Philosophy program in Social, Financial and Administrative Pharmacy (SEAP), College of Pharmacy, Mahidol College, Bangkok. Apart from, this research was supported by grants from the Worldwide Analysis Community-The Thailand Analysis Fund (IRN60W003) and Well being Techniques Analysis Institute (HSRI61-080), Thailand. Nevertheless, the funders had no function within the design, conduct of the research; assortment, administration, evaluation and interpretation of information, and preparation of the manuscript. We want to thank Miss. Waranya Rattanavipapong for her worthwhile recommendation. Our gratitude can also be prolonged to all sufferers who participated on this research.
Disclosure
The authors declare no conflicts of curiosity in relation to this work.
References
1. The Thai Working Group on Burden of Illness and Accidents. Burden of illness and accidents in Thailand; 2002.
2. Nation factsheets Thailand; 2019. Obtainable from: https://www.unaids.org/en/regionscountries/nations/Thailand.
3. HIV Epidemic. Obtainable from: https://hivhub.ddc.moph.go.th/epidemic.php.
4. Manosuthi W, Ongwandee S, Bhakeecheep S, et al. Tips for antiretroviral remedy in HIV-1 contaminated adults and adolescents 2014, Thailand. AIDS Res Ther. 2015;12:12. doi:10.1186/s12981-015-0053-z
5. Adolescents PoAGfAa. Tips for the usage of antiretroviral brokers in adults and adolescents with HIV. Division of Well being and Human Companies. Obtainable from: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
6. Division of Illness Management, Ministry of Public Well being. Thailand Nationwide Tips on HIV/AIDS Analysis, Remedy and Prevention 2020/2021. Thailand: Division of Illness Management, Ministry of Public Well being; 2020.
7. Rodríguez-Nóvoa S, Barreiro P, Jiménez-Nácher I, Soriano V. Overview of the pharmacogenetics of HIV remedy. Pharmacogenomics J. 2006;6(4):234–245. doi:10.1038/sj.tpj.6500374
8. Whirl-Carrillo M, Huddart R, Gong L, et al. An evidence-based framework for evaluating pharmacogenomics information for personalised medication. Clin Pharmacol Ther. 2021;110(3):563–572. doi:10.1002/cpt.2350
9. Tangamornsuksan W, Lohitnavy O, Kongkaew C, et al. Affiliation of HLA-B*5701 genotypes and Abacavir-induced hypersensitivity response: a scientific assessment and meta-analysis. J Pharm Pharm Sci. 2015;18(1):68–76. doi:10.18433/j39s3t
10. US Meals and Drug Administration. Desk of pharmacogenetic associations. Obtainable from: https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations.
11. Wang C-W, Tassaneeyakul W, Chen C-B, et al. Entire genome sequencing identifies genetic variants related to co-trimoxazole hypersensitivity in Asians. J Allergy Clin Immunol. 2021;147(4):1402–1412. doi:10.1016/j.jaci.2020.08.003
12. Sukasem C, Pratoomwun J, Satapornpong P, et al. Genetic affiliation of co-trimoxazole-induced extreme cutaneous adversarial reactions is phenotype-specific: HLA class I genotypes and haplotypes. Clin Pharmacol Ther. 2020;108(5):1078–1089. doi:10.1002/cpt.1915
13. Wang PY, Xie SY, Hao Q, Zhang C, Jiang BF. NAT2 polymorphisms and susceptibility to anti-tuberculosis drug-induced liver damage: a meta-analysis. Int J Tuberc Lung Dis. 2012;16(5):589–595. doi:10.5588/ijtld.11.0377
14. Richardson M, Kirkham J, Dwan Okay, Sloan DJ, Davies G, Jorgensen AL. NAT2 variants and toxicity associated to anti-tuberculosis brokers: a scientific assessment and meta-analysis. Int J Tuberc Lung Dis. 2019;23(3):293–305. doi:10.5588/ijtld.18.0324
15. Sukasem C, Jantararoungtong T, Koomdee N. Pharmacogenomics analysis and its medical implementation in Thailand: classes realized from the resource-limited settings. Drug Metab Pharmacokinet. 2021;39:100399. doi:10.1016/j.dmpk.2021.100399
16. Payne Okay, Shabaruddin FH. Value-effectiveness evaluation in pharmacogenomics. Pharmacogenomics. 2010;11(5):643–646. doi:10.2217/pgs.10.45
17. Division of Medical Companies; Ministry of Public Well being AND Infectious Illness Affiliation of Thailand. Medical Observe Guideline (CPG) of Tuberculosis Remedy in Thailand. Division of Medical Companies; Ministry of Public Well being; 2018.
18. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487–2498. doi:10.1056/NEJMra032588
19. Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Profitable intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med. 1987;316(26):1627–1632. doi:10.1056/nejm198706253162604
20. Awad WB, Asaad A, Al-Yasein N, Najjar R. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in grownup hematopoietic stem cell transplant sufferers: a retrospective research. BMC Infect Dis. 2020;20(1):400. doi:10.1186/s12879-020-05127-y
21. Crozier F. Pneumocystis carinii pneumonia prophylaxis: present therapies and suggestions. J Pediatr Oncol Nurs. 2011;28(3):179–184. doi:10.1177/1043454211408101
22. World Well being Group. Tips on Co-Trimoxazole Prophylaxis for HIV-Associated Infections Amongst Youngsters, Adolescents and Adults: Suggestions for a Public Well being Method. World Well being Group; 2006.
23. World Well being Group. Tips for remedy of tuberculosis, 4th ed. Obtainable from: http://www.who.int/tb/publications/2010/9789241547833/en/.
24. Division of Illness Management, Ministry of Public Well being. Thailand Nationwide Tips on TB/HIV 2017. Thailand: Division of Illness Management, Ministry of Public Well being; 2020.
25. Azuma J, Ohno M, Kubota R, et al. NAT2 genotype guided routine reduces isoniazid-induced liver damage and early remedy failure within the 6-month four-drug commonplace remedy of tuberculosis: a randomized managed trial for pharmacogenetics-based remedy. Eur J Clin Pharmacol. 2013;69(5):1091–1101. doi:10.1007/s00228-012-1429-9
26. Kinzig-Schippers M, Tomalik-Scharte D, Jetter A, et al. Ought to we use N-acetyltransferase sort 2 genotyping to personalize isoniazid doses? Antimicrob Brokers Chemother. 2005;49(5):1733–1738. doi:10.1128/aac.49.5.1733-1738.2005
27. Kubota R, Ohno M, Hasunuma T, Iijima H, Azuma J. Dose-escalation research of isoniazid in wholesome volunteers with the fast acetylator genotype of arylamine N-acetyltransferase 2. Eur J Clin Pharmacol. 2007;63(10):927–933. doi:10.1007/s00228-007-0333-1
28. Tan-Torres Edejer T, Baltussen R, Adam T, et al. Making Selections in Well being: WHO Information to Value-Effectiveness Evaluation. World Well being Group; 2003.
29. Chaikledkaew U, Teerawattananon Y. Tips for Well being Know-how Evaluation in Thailand.
30. Admera Well being PGxOne™ Plus. Genetic testing registry. NCBI. Obtainable from: https://www.ncbi.nlm.nih.gov/gtr/assessments/567653/performance-characteristics/.
31. Ningsanon P, Supawitkul S, Srisongsom S, Boason T, Nutchom Okay. CD4 monitoring in HIV contaminated sufferers not eligible for receiving ARV in 2004–2006. Dis Management J. 2008;34(1):11–21.
32. Rojanawiwat A, Tsuchiya N, Pathipvanich P, et al. Influence of the Nationwide Entry to Antiretroviral Program on the incidence of opportunistic infections in Thailand. Int Well being. 2011;3(2):101–107. doi:10.1016/j.inhe.2010.12.004
33. Wattanapokayakit S, Mushiroda T, Yanai H, et al. NAT2 sluggish acetylator related to anti-tuberculosis drug-induced liver damage in Thai sufferers. Int J Tuberc Lung Dis. 2016;20(10):1364–1369. doi:10.5588/ijtld.15.0310
34. Tempark T, Satapornpong P, Rerknimitr P, et al. Dapsone-induced extreme cutaneous adversarial drug reactions are strongly linked with HLA-B*13: 01 allele within the Thai inhabitants. Pharmacogenet Genomics. 2017;27(12):429–437. doi:10.1097/fpc.0000000000000306
35. Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to Abacavir. N Engl J Med. 2008;358(6):568–579. doi:10.1056/NEJMoa0706135
36. Leelahavarong P, Teerawattananon Y, Werayingyong P, et al. Is a HIV vaccine a viable choice and at what value? An financial analysis of including HIV vaccination into present prevention applications in Thailand. BMC Public Well being. 2011;11:534. doi:10.1186/1471-2458-11-534
37. Maleewong U, Kulsomboon V, Teerawattananon Y. The price-effectiveness evaluation of initiating HIV/AIDS remedy with efavirenz-based regimens in contrast with nevirapine-based regimens in Thailand. J Med Assoc Thai. 2008;91(Suppl 2):S126–38.
38. Leelukkanaveera Y. An Financial Analysis of Routine Supply HIV Counseling and Testing of Out Sufferers at Group Hospitals in Thailand. Chulalongkorn College; 2009.
39. Plumpton CO, Yip VL, Alfirevic A, Marson AG, Pirmohamed M, Hughes DA. Value-effectiveness of screening for HLA-A*31:01 previous to initiation of carbamazepine in epilepsy. Epilepsia. 2015;56(4):556–563. doi:10.1111/epi.12937
40. Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: half I. Medical views. J Am Acad Dermatol. 2013;68(5):
41. Mo P, Zhu Q, Teter C, et al. Prevalence, drug-induced hepatotoxicity, and mortality amongst sufferers multi-infected with HIV, tuberculosis, and hepatitis virus. Int J Infect Dis. 2014;28:95–100. doi:10.1016/j.ijid.2014.06.020
42. Ministry of Commerce. Report for shopper value index of Thailand. Obtainable from: http://www.indexpr.moc.go.th/price_present/TableIndexG_region.asp?table_name=cpig_index_country&province_code=5&type_code=g&check_f=i&year_base=2562&nyear=2552.
43. Ministry of Public Well being. Drug And Medical Provide Info Middle. Obtainable from: http://dmsic.moph.go.th/index/drugsearch/1.
44. Division of Medical Sciences MoPH. Service payment for evaluation and repair. Availabe from: https://www3.dmsc.moph.go.th/.
45. Kauf TL, Roskell N, Shearer A, et al. A predictive mannequin of well being state utilities for HIV sufferers within the trendy period of extremely lively antiretroviral remedy. Worth Well being. 2008;11(7):1144–1153. doi:10.1111/j.1524-4733.2008.00326.x
46. Sadatsafavi M, Marra C, Marra F, Moran O, FitzGerald JM, Lynd L. A quantitative benefit-risk evaluation of isoniazid for remedy of latent tuberculosis an infection utilizing incremental profit framework. Worth Well being. 2013;16(1):66–75. doi:10.1016/j.jval.2012.09.006
47. Wolf E, Blankenburg M, Bogner JR, et al. Value impression of potential HLA-B*5701-screening previous to Abacavir/lamivudine mounted dose mixture use in Germany. Eur J Med Res. 2010;15(4):145–151. doi:10.1186/2047-783X-15-4-145
48. Kapoor R, Martinez-Vega R, Dong D, et al. Lowering hypersensitivity reactions with HLA-B*5701 genotyping earlier than Abacavir prescription: clinically helpful however is it cost-effective in Singapore? Pharmacogenet Genomics. 2015;25(2):60–72. doi:10.1097/fpc.0000000000000107
49. Satapornpong P, Jinda P, Jantararoungtong T, et al. Genetic range of HLA class I and Class II alleles in Thai populations: contribution to genotype-guided therapeutics. Entrance Pharmacol. 2020;11:78. doi:10.3389/fphar.2020.00078
50. Retno WS, Kinasih P, Intan R, Syukrini B, Rika Y. Excessive frequency of NAT2 sluggish acetylator alleles within the Malay inhabitants of Indonesia: an consciousness to the anti-tuberculosis drug induced liver damage and most cancers. Med J Indones. 2017;26(1). doi:10.13181/mji.v26i1.1563
51. DeJesus E, Herrera G, Teofilo E, et al. Abacavir versus zidovudine mixed with lamivudine and efavirenz, for the remedy of antiretroviral-naive HIV-infected adults. Clin Infect Dis. 2004;39(7):1038–1046. doi:10.1086/424009
52. Goris A, Walton A, Ban M, Dubois B, Compston A, Sawcer S. A Taqman assay for high-throughput genotyping of the a number of sclerosis-associated HLA-DRB1*1501 allele. Tissue Antigens. 2008;72(4):401–403. doi:10.1111/j.1399-0039.2008.01101.x
53. Goldie SJ, Kaplan JE, Losina E, et al. Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: utilizing simulation modeling to tell medical pointers. Arch Intern Med. 2002;162(8):921–928. doi:10.1001/archinte.162.8.921
54. Rebecca E. Sanger sequencing: previous successes and present purposes. Obtainable from: https://www.cytivalifesciences.com/en/us/news-center/sanger-sequencing-past-and-present-10001.
55. Reslova N, Michna V, Kasny M, Mikel P, Kralik P. xMAP know-how: purposes in detection of pathogens. Entrance Microbiol. 2017;8:55. doi:10.3389/fmicb.2017.00055
